The global Cannabidiol Nutraceuticals Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Product (CBD Tinctures, Capsules & Soft Gels, CBD Gummies, Others), By Application (Pharmacies, Retail Stores, Online)
The plant-based cannabidiol (CBD) nutraceuticals market is experiencing rapid expansion in 2024, driven by increasing consumer interest in natural remedies and holistic wellness solutions. Derived from hemp and other cannabis plants, CBD is renowned for its potential therapeutic benefits, including pain relief, anxiety reduction, and stress management, without the psychoactive effects associated with THC. As consumers seek alternatives to traditional pharmaceuticals, the demand for CBD-infused nutraceutical products such as oils, capsules, tinctures, and edibles is soaring. Moreover, the shift towards plant-based lifestyles and the legalization of cannabis in various regions are further fueling market growth. However, regulatory complexities and quality control remain key challenges for industry stakeholders as they navigate this rapidly evolving landscape.
The market report analyses the leading companies in the industry including Charlotte’s Web, CV Sciences Inc, Diamond CBD, Elixinol, Foria Wellness, Garden Of Life, Green Roads, Irwin Naturals, Isodiol, Medical Marijuana Inc, and Others.
The most prominent trend in the Plant-Based Cannabidiol (CBD) Nutraceuticals Market is the increasing acceptance and legalization of CBD products. As regulations around CBD use become more favorable, there is a growing demand for CBD-infused nutraceuticals that offer various health benefits. This trend is driven by the rising awareness of the potential therapeutic effects of CBD, such as pain relief, anxiety reduction, and improved sleep. The market is seeing a surge in new product launches and consumer interest in plant-based CBD nutraceuticals
The health and wellness movement is a major driver of the Plant-Based CBD Nutraceuticals Market. Consumers are increasingly seeking natural and holistic approaches to health, and CBD products align with these preferences. The potential health benefits of CBD, combined with its natural origin, make it appealing to health-conscious consumers. The growing focus on preventive healthcare and the desire for natural remedies are driving the demand for plant-based CBD nutraceuticals
A significant opportunity in the Plant-Based CBD Nutraceuticals Market lies in the expansion of product portfolios. As consumer interest in CBD products grows, there is potential for companies to introduce a wide range of CBD-infused nutraceuticals, including supplements, topicals, and edibles. By diversifying their product offerings and targeting different health concerns, such as stress, inflammation, and sleep disorders, companies can attract a broader audience and increase market penetration. The development of innovative and high-quality CBD products can help capture a larger share of the growing market
The powder segment is expected to be the fastest-growing in the Oligosaccharides in the Infant Nutrition Market by type to 2032. Powdered oligosaccharides are widely used in infant formula and other nutritional products due to their stability, ease of storage, and longer shelf life. The demand for powdered oligosaccharides is driven by the increasing awareness of the health benefits of oligosaccharides, including their role in promoting gut health and supporting the immune system. Additionally, the growing trend of clean label and organic products in the infant nutrition market contributes to the segment's rapid growth. The expansion of the infant formula market and the increasing use of powdered oligosaccharides in various formulations support the growth of this segment.
The health products segment is anticipated to be the fastest-growing in the Oligosaccharides in the Infant Nutrition Market by application to 2032. The demand for oligosaccharides in health products is driven by the increasing focus on promoting gut health and overall well-being in infants. Oligosaccharides are used in various health products, including supplements and functional foods, to support the development of a healthy gut microbiome and enhance immune function. Additionally, the growing awareness of the long-term health benefits of oligosaccharides and the rising trend of preventive healthcare contribute to the segment's rapid growth. The expansion of the health products market and the increasing incorporation of oligosaccharides in various formulations support the growth of this segment.
By Product
CBD Tinctures
Capsules & Soft Gels
CBD Gummies
Others
By Application
Pharmacies
Retail Stores
Online
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Charlotte’s Web
CV Sciences Inc
Diamond CBD
Elixinol
Foria Wellness
Garden Of Life
Green Roads
Irwin Naturals
Isodiol
Medical Marijuana Inc
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Cannabidiol Nutraceuticals Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Cannabidiol Nutraceuticals Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Cannabidiol Nutraceuticals Market Share by Company, 2023
4.1.2. Product Offerings of Leading Cannabidiol Nutraceuticals Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Cannabidiol Nutraceuticals Market Drivers
6.2. Cannabidiol Nutraceuticals Market Challenges
6.6. Cannabidiol Nutraceuticals Market Opportunities
6.4. Cannabidiol Nutraceuticals Market Trends
Chapter 7. Global Cannabidiol Nutraceuticals Market Outlook Trends
7.1. Global Cannabidiol Nutraceuticals Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Cannabidiol Nutraceuticals Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Cannabidiol Nutraceuticals Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Product
CBD Tinctures
Capsules & Soft Gels
CBD Gummies
Others
By Application
Pharmacies
Retail Stores
Online
Chapter 8. Global Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.1. Global Cannabidiol Nutraceuticals Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Cannabidiol Nutraceuticals Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.2.2. Canada Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.2.3. Mexico Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.3. Europe Cannabidiol Nutraceuticals Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.3.2. France Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.3.3. United Kingdom Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.3.4. Spain Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.3.5. Italy Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.3.6. Russia Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.3.7. Rest of Europe Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.4. Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million) by Country (2021-2032)
8.4.1. China Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.4.2. Japan Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.4.3. India Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.4.4. South Korea Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.4.5. Australia Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.4.6. South East Asia Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.5. South America Cannabidiol Nutraceuticals Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.5.2. Argentina Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.5.3. Rest of South America Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.6. Middle East and Africa Cannabidiol Nutraceuticals Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Cannabidiol Nutraceuticals Regional Analysis and Outlook
8.6.2. Africa Cannabidiol Nutraceuticals Regional Analysis and Outlook
Chapter 9. North America Cannabidiol Nutraceuticals Analysis and Outlook
9.1. North America Cannabidiol Nutraceuticals Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Cannabidiol Nutraceuticals Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Cannabidiol Nutraceuticals Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Cannabidiol Nutraceuticals Revenue (USD Million) by Product (2021-2032)
By Product
CBD Tinctures
Capsules & Soft Gels
CBD Gummies
Others
By Application
Pharmacies
Retail Stores
Online
Chapter 10. Europe Cannabidiol Nutraceuticals Analysis and Outlook
10.1. Europe Cannabidiol Nutraceuticals Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Cannabidiol Nutraceuticals Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Cannabidiol Nutraceuticals Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Cannabidiol Nutraceuticals Revenue (USD Million) by Product (2021-2032)
By Product
CBD Tinctures
Capsules & Soft Gels
CBD Gummies
Others
By Application
Pharmacies
Retail Stores
Online
Chapter 11. Asia Pacific Cannabidiol Nutraceuticals Analysis and Outlook
11.1. Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million) by Product (2021-2032)
By Product
CBD Tinctures
Capsules & Soft Gels
CBD Gummies
Others
By Application
Pharmacies
Retail Stores
Online
Chapter 12. South America Cannabidiol Nutraceuticals Analysis and Outlook
12.1. South America Cannabidiol Nutraceuticals Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Cannabidiol Nutraceuticals Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Cannabidiol Nutraceuticals Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Cannabidiol Nutraceuticals Revenue (USD Million) by Product (2021-2032)
By Product
CBD Tinctures
Capsules & Soft Gels
CBD Gummies
Others
By Application
Pharmacies
Retail Stores
Online
Chapter 13. Middle East and Africa Cannabidiol Nutraceuticals Analysis and Outlook
13.1. Middle East and Africa Cannabidiol Nutraceuticals Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Cannabidiol Nutraceuticals Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Cannabidiol Nutraceuticals Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Cannabidiol Nutraceuticals Revenue (USD Million) by Product (2021-2032)
By Product
CBD Tinctures
Capsules & Soft Gels
CBD Gummies
Others
By Application
Pharmacies
Retail Stores
Online
Chapter 14. Cannabidiol Nutraceuticals Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
Charlotte’s Web
CV Sciences Inc
Diamond CBD
Elixinol
Foria Wellness
Garden Of Life
Green Roads
Irwin Naturals
Isodiol
Medical Marijuana Inc
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Cannabidiol Nutraceuticals Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Cannabidiol Nutraceuticals Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Cannabidiol Nutraceuticals Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Cannabidiol Nutraceuticals Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Cannabidiol Nutraceuticals Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Cannabidiol Nutraceuticals Market Share (%) By Regions (2021-2032)
Table 12 North America Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Table 15 South America Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Cannabidiol Nutraceuticals Revenue (USD Million) By Region (2021-2032)
Table 17 North America Cannabidiol Nutraceuticals Revenue (USD Million) By Type (2021-2032)
Table 18 North America Cannabidiol Nutraceuticals Revenue (USD Million) By Application (2021-2032)
Table 19 North America Cannabidiol Nutraceuticals Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Cannabidiol Nutraceuticals Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Cannabidiol Nutraceuticals Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Cannabidiol Nutraceuticals Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million) By Product (2021-2032)
Table 26 South America Cannabidiol Nutraceuticals Revenue (USD Million) By Type (2021-2032)
Table 27 South America Cannabidiol Nutraceuticals Revenue (USD Million) By Application (2021-2032)
Table 28 South America Cannabidiol Nutraceuticals Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Cannabidiol Nutraceuticals Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Cannabidiol Nutraceuticals Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Cannabidiol Nutraceuticals Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Cannabidiol Nutraceuticals Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Cannabidiol Nutraceuticals Market Share (%) By Regions (2023)
Figure 6. North America Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 12. France Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 12. China Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 14. India Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Cannabidiol Nutraceuticals Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Cannabidiol Nutraceuticals Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Cannabidiol Nutraceuticals Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Cannabidiol Nutraceuticals Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Cannabidiol Nutraceuticals Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Cannabidiol Nutraceuticals Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Cannabidiol Nutraceuticals Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Cannabidiol Nutraceuticals Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Cannabidiol Nutraceuticals Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Cannabidiol Nutraceuticals Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Cannabidiol Nutraceuticals Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Cannabidiol Nutraceuticals Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Cannabidiol Nutraceuticals Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Cannabidiol Nutraceuticals Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Cannabidiol Nutraceuticals Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Cannabidiol Nutraceuticals Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Cannabidiol Nutraceuticals Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Cannabidiol Nutraceuticals Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Cannabidiol Nutraceuticals Revenue (USD Million) By Product (2021-2032)
By Product
CBD Tinctures
Capsules & Soft Gels
CBD Gummies
Others
By Application
Pharmacies
Retail Stores
Online
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Cannabidiol Nutraceuticals Market Size is valued at $4.9 Billion in 2024 and is forecast to register a growth rate (CAGR) of 7.2% to reach $8.5 Billion by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Charlotte’s Web, CV Sciences Inc, Diamond CBD, Elixinol, Foria Wellness, Garden Of Life, Green Roads, Irwin Naturals, Isodiol, Medical Marijuana Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume